A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

NCT00337376 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Cancers

Interventions

DRUG: Rapamune
DRUG: Abraxane

Sponsor

Yale University

Collaborators

[object Object]